← All trials
NCT01621789
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2012
- Primary completion
- Jul 31, 2013
- Completion date
- May 31, 2014
- First posted
- Jun 18, 2012
- Last posted
- Mar 16, 2016
- Enrollment
- 25
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Federal University of Sao PauloLead sponsor
- Federal University of Sao PauloReponsible party - principal investigator
- Federal University of Sao PauloSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.